Ohio
Cancer surgery and procedure trials in Ohio
130 cancer surgery and procedure studies are recruiting participants at sites in 61 cities across Ohio as of November 18, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Ohio city with a recruiting study
By research area: Lymphoma (42), Lung Cancer (31), Breast Cancer (21), Prostate Cancer (16), Pancreatic Cancer (11), Melanoma (9).
Columbus (103), Cleveland (40), Cincinnati (35), Dayton (29), Centerville (22), Franklin (21), Greenville (21), Troy (19), Canton (18), Toledo (17), Sylvania (15), Akron (14), West Chester (13), Westerville (11), Avon (10), Delaware (10), Mansfield (10), Marion (10), Belpre (9), Chillicothe (9), Dublin (9), Newark (9), Springfield (9), Beachwood (8), Marysville (8), Zanesville (8), Kettering (7), Mentor (7), Mount Vernon (7), Perrysburg (7), Portsmouth (7), Pickerington (6), Athens (5), Grove City (5), Lancaster (5), Marietta (5), Mayfield Heights (5), Barberton (3), Beavercreek (3), Boardman (3), Findlay (3), Medina (3), Warren (3), Youngstown (3), Independence (2), Sandusky (2), Steubenville (2), Wooster (2), Alliance (1), Chardon (1), Gahanna (1), Lima (1), Middleburg Heights (1), New Albany (1), Orange (1), Parma (1), Ravenna (1), Strongsville (1), Warrensville Heights (1), Westlake (1), Wilmington (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Breast cancer: recently updated in Ohio
Basic details from each study's public record (the 12 most recently updated of 130). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Columbus
- Registry record
- NCT03606967 · updated
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Columbus
- Registry record
- NCT05422794 · updated
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Phase 2
- All ages
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Athens · Avon · Beachwood · and 29 more U.S. locations
- Registry record
- NCT05564377 · updated
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
- Phase 2
- Ages 35 and older
- Female participants
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Columbus
- Registry record
- NCT05941520 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Ohio on ClinicalTrials.gov.
Lung cancer: recently updated in Ohio
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Cleveland · Columbus
- Registry record
- NCT04665739 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Ohio on ClinicalTrials.gov.
Prostate cancer: recently updated in Ohio
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Belpre · Chillicothe · Columbus · and 13 more U.S. locations
- Registry record
- NCT03866382 · updated
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
- Phase 2
- Ages 18 and older
- Male participants
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Columbus
- Registry record
- NCT05691465 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Ohio on ClinicalTrials.gov.
Melanoma: recently updated in Ohio
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Centerville · Dayton · Franklin · and 2 more U.S. locations
- Registry record
- NCT05136196 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Ohio on ClinicalTrials.gov.
Lymphoma: recently updated in Ohio
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Cincinnati · Columbus · West Chester
- Registry record
- NCT03739814 · updated
Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Columbus
- Registry record
- NCT04301076 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Ohio on ClinicalTrials.gov.
Pancreatic cancer: recently updated in Ohio
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Centerville · Dayton · Franklin · and 2 more U.S. locations
- Registry record
- NCT04858334 · updated
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Columbus
- Registry record
- NCT05372614 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Ohio on ClinicalTrials.gov.
Ask about studies in Ohio
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a surgery or another procedure, as each study is coded in the registry.
Cancer Surgery Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections